ArticleCancer2020

Intratumor heterogeneity could inform the use and type of postoperative adjuvant therapy in patients with head and neck squamous cell carcinoma.

Edmund A Mroz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.